- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03144375
QOL Outcomes in CRS With Polyps
Comparison of Outcomes After Peri-operative Optimization and Standard Surgical Treatment or Standard of Care Surgical Treatment in Patients Who Have Chronic Rhinosinusitis With Polyposis.
Chronic rhinosinusits (CRS) is common disease with reports of prevalence ranging from 4-16% in the western population. The main outcome measure for chronic disease treatment, such as CRS, is quality of life. Several large multi-institutional studies have shown that improvement in disease specific Quality of life was greater in patients who had surgery for their CRS with polyps. The timing of surgery in these patients has not been well studied but it is generally agreed upon that surgical candidates much had failed medical management. The definition of medical management varies greatly but usually includes some form of nasal or oral steroids and a prolonged ( >10 days) course of antibiotics.
Another known way to improve QOL is through education and individualized optimization. This has been utilized successfully in other fields with good success and improved QOL. Similar studies looking at combining non-surgical optimization and education have not been performed in CRS. This study aims to address this potential area for improvement in patient quality of life outcomes. Investigators plan to assess the potential role for pre-operative non-surgical medical and educational optimization in CRS standard of care treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33129
- University of Miami
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults with Rhinosinusitis with polyps who have had appropriate treatment qualifying them for surgery and are good surgical candidates
Exclusion Criteria:
- Cystic fibrosis, Cilia disorders, other specialized forms of sinus disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Medical Optimization
Medical treatment and education x 4 months, re- eval at 4 months and possible cross-over to surgery
|
Medical treatment and education about the sinusitis disease process prior to surgery as compared to baseline surgical and treatment counseling
|
|
Active Comparator: Surgical treatment
Surgical treatment up front
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
SNOT-22
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20151068
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Rhinosinusitis, Polyps
-
Region SkaneRecruitingChronic Rhinosinusitis With Nasal Polyps | Chronic Rhinosinusitis Without Nasal PolypsSweden
-
Polyganics BVNAMSANot yet recruitingChronic Rhinosinusitis (CRS) With and Without Nasal Polyps | Chronic Rhinosinusitis (CRS)
-
AstraZenecaRecruitingChronic Rhinosinusitis With Nasal PolypsChina
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Not yet recruiting
-
AstraZenecaRecruitingChronic Rhinosinusitis With Nasal PolypsChina
-
SanofiRegeneron PharmaceuticalsNot yet recruiting
-
Rigshospitalet, DenmarkRecruitingChronic Rhinosinusitis With Nasal PolypsDenmark
-
SanofiRegeneron PharmaceuticalsEnrolling by invitationChronic Rhinosinusitis With Nasal PolypsUnited Kingdom, United States, Australia, China, Chile, South Korea, Canada
-
Tang-Du HospitalRecruitingEosinophilic Chronic Rhinosinusitis With Nasal PolypsChina
-
Longbio PharmaNot yet recruitingChronic Rhinosinusitis With Nasal Polyps (CRSwNP)China
Clinical Trials on Medical optimization and education
-
Institut CurieActive, not recruitingCarcinoma, Non-Small-Cell Lung | Advanced CancerFrance
-
University of ChicagoNorthwestern University; Ann & Robert H Lurie Children's Hospital of Chicago; Howard Brown Health Center and other collaboratorsCompleted
-
Carrick Institute for Graduate StudiesCompleted
-
University Hospital, Gentofte, CopenhagenRigshospitalet, Denmark; Lund University HospitalUnknownHeart Failure | Ischemic CardiomyopathyDenmark, Sweden
-
The University of Hong KongRecruitingFrailty | Coronary Artery Bypass Grafting | Transcatheter Aortic Valve Implantation | Heart Valve ReplacementHong Kong
-
Shanxi Dayi HospitalUnknown
-
Çanakkale Onsekiz Mart UniversityEnrolling by invitationEducation, Medical | Alexithymia | Health Equity | Empathy Skills | Social Justice AdvocacyTurkey (Türkiye)
-
Washington State, Department of HealthUniversity of Washington; NorthWest Orthopaedic Institute; Spokane Regional Health... and other collaboratorsCompleted
-
Pham Ngoc Thach University of MedicineEnrolling by invitation
-
Harvard Medical School (HMS and HSDM)National Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Diabetes MellitisUnited States